Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

In this multicenter, randomized, controlled phase III trial, 412 patients were randomly assigned to two groups. One group was given minocycline in escalating doses of up to 400 mg per day for 9 ...

The new capsule formulation of the antibiotic minocycline hydrochloride has been ... It ran a pair of phase 3 trials that showed a superior effect on Investigator's Global Assessment, as well ...

score of 3 or 4, indicating moderate or severe disease. At 16 weeks, a higher proportion of patients in the minocycline ...